miR-339-3p inhibits proliferation and metastasis of colorectal cancer

被引:40
|
作者
Zhou, Chang [1 ]
Lu, Yenxia [2 ]
Li, Xuenong [2 ]
机构
[1] Guangdong Pharmaceut Univ, Dept Anat & Histol, Guangzhou 510006, Guangdong, Peoples R China
[2] Southern Med Univ, Sch Basic Med Sci, Dept Pathol, Guangzhou 510515, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
miR-339-3p; colorectal cancer; proliferation; metastasis; TUMOR-GROWTH; PROGRESSION; MICRORNAS; CELLS;
D O I
10.3892/ol.2015.3661
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MicroRNAs (miRNAs) serve important roles in regulating cancer cell proliferation and metastasis. The same hairpin RNA structure may produce mature products from each strand, termed miR-5p and miR-3p, which can bind different mRNAs. Previously, the present authors reported that miR-339-5p could inhibit cell proliferation and migration by targeting the 3'-untranslated region (3'-UTR) of PRL-1 mRNA. The present study analyzed the expression, function and preliminary regulatory mechanism of miR-339-3p in colorectal cancer (CRC). The results of reverse transcription-quantitative polymerase chain reaction analysis demonstrated that miR-339-3p is downregulated in CRC specimens and highly invasive cell lines. Furthermore, the low-level expression of miR-339-3p was significantly associated with lymph node metastasis in patients with CRC; however, reduced miR-339-3p expression was not associated with age, gender or the differentiation status of the tumor. Overexpression of miR-339-3p was sufficient to suppress tumor growth and metastasis in vitro. In addition, the present study demonstrated that unlike miR-339-5p, PRL-1 expression was not regulated by miR-339-3p. The findings of the present study indicate that miR-339-5p and miR-339-3p may target different mRNA. The target gene of miR-339-3p requires future identification.
引用
收藏
页码:2842 / 2848
页数:7
相关论文
共 50 条
  • [21] Locked nucleic acid inhibits miR-92a-3p in human colorectal cancer, induces apoptosis and inhibits cell proliferation
    S Ahmadi
    M Sharifi
    R Salehi
    Cancer Gene Therapy, 2016, 23 : 199 - 205
  • [22] Locked nucleic acid inhibits miR-92a-3p in human colorectal cancer, induces apoptosis and inhibits cell proliferation
    Ahmadi, S.
    Sharifi, M.
    Salehi, R.
    CANCER GENE THERAPY, 2016, 23 (07) : 199 - 205
  • [23] MiR-182-5p inhibited proliferation and metastasis of colorectal cancer by targeting MTDH
    Jin, Y.
    Zhang, Z-L
    Huang, Y.
    Zhang, K-N
    Xiong, B.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (04) : 1494 - 1501
  • [24] MiR-384 inhibits the proliferation of colorectal cancer by targeting AKT3
    Wang, Yong-Xia
    Zhu, Hui-Fang
    Zhang, Zhe-Ying
    Ren, Feng
    Hu, Yu-Han
    CANCER CELL INTERNATIONAL, 2018, 18
  • [25] MiR-384 inhibits the proliferation of colorectal cancer by targeting AKT3
    Yong-Xia Wang
    Hui-Fang Zhu
    Zhe-Ying Zhang
    Feng Ren
    Yu-Han Hu
    Cancer Cell International, 18
  • [26] miR-145-5p suppresses proliferation, metastasis and EMT of colorectal cancer by targeting CDCA3
    Chen, Qing
    Zhou, Lin
    Ye, Xia
    Tao, Min
    Wu, Jie
    PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (04)
  • [27] miR-627-3p inhibits osteosarcoma cell proliferation and metastasis by targeting PTN
    He, Ming
    Shen, Peng
    Qiu, Chuang
    Wang, Jiashi
    AGING-US, 2019, 11 (15): : 5744 - 5756
  • [28] Sapindus Saponin Inhibits Colorectal Cancer cell Proliferation and Metastasis by regulating microRNA-5590-3p expression
    Zhang, Yanping
    Wang, Xiaojun
    Cao, Ping
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 85 (06) : 1805 - 1810
  • [29] SPTBN2 regulated by miR-214-3p inhibits the proliferation and migration of colorectal cancer cells
    Chen, Chunlin
    Zhang, Qianshi
    Wang, Bo
    Song, Yang
    Feng, Zhen
    Ren, Shuangyi
    CELLULAR AND MOLECULAR BIOLOGY, 2023, 69 (14) : 126 - 131
  • [30] miR-339-3p inhibits cell growth and epithelial–mesenchymal transition in nasopharyngeal carcinoma by modulating the KAT6A/TRIM24 axis
    Pei Gao
    Kun Zhao
    Wuhao Lu
    Liang Wang
    Peng Zhang
    International Journal of Clinical Oncology, 2022, 27 : 1684 - 1697